Stericycle Inc. (NASDAQ:SRCL) had its price target lowered by equities research analysts at Wedbush from $95.00 to $85.00 in a report issued on Thursday. The firm currently has a “neutral” rating on the stock. Wedbush’s target price points to a potential upside of 8.97% from the stock’s previous close.

A number of other research firms also recently commented on SRCL. Zacks Investment Research downgraded shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Thursday, July 14th. Imperial Capital reduced their price objective on shares of Stericycle from $100.00 to $95.00 and set an “in-line” rating on the stock in a research note on Thursday, May 26th. Royal Bank Of Canada reiterated a “sell” rating on shares of Stericycle in a research note on Thursday, May 26th. Northcoast Research downgraded shares of Stericycle from a “buy” rating to a “neutral” rating in a research note on Tuesday. Finally, Jefferies Group reiterated a “buy” rating and set a $125.00 price objective (down from $140.00) on shares of Stericycle in a research note on Friday, July 29th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. Stericycle presently has an average rating of “Hold” and a consensus target price of $108.95.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Stericycle (NASDAQ:SRCL) opened at 78.00 on Thursday. The firm has a market capitalization of $6.63 billion, a price-to-earnings ratio of 27.46 and a beta of 0.27. The firm has a 50-day moving average of $84.48 and a 200-day moving average of $102.42. Stericycle has a 1-year low of $76.76 and a 1-year high of $151.57.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/stericycle-inc-srcl-given-new-85-00-price-target-at-wedbush.html

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.18. The business earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The business’s revenue was up 24.6% on a year-over-year basis. During the same period last year, the business earned $1.14 EPS. On average, analysts expect that Stericycle will post $4.67 earnings per share for the current year.

In related news, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total value of $114,426.30. Following the sale, the executive vice president now directly owns 1,088 shares in the company, valued at approximately $89,052.80. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Mark C. Miller sold 34,835 shares of Stericycle stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the completion of the sale, the director now owns 244,284 shares in the company, valued at $25,532,563.68. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently modified their holdings of SRCL. Norges Bank purchased a new stake in shares of Stericycle during the fourth quarter valued at $76,432,000. Chevy Chase Trust Holdings Inc. boosted its position in Stericycle by 5.2% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 74,656 shares of the company’s stock valued at $9,421,000 after buying an additional 3,659 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in Stericycle by 15.6% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 16,521 shares of the company’s stock valued at $2,085,000 after buying an additional 2,227 shares during the last quarter. Exxonmobil Investment Management Inc. TX boosted its position in Stericycle by 8.6% in the first quarter. Exxonmobil Investment Management Inc. TX now owns 20,692 shares of the company’s stock valued at $2,611,000 after buying an additional 1,643 shares during the last quarter. Finally, GW&K Investment Management LLC boosted its position in Stericycle by 26.1% in the first quarter. GW&K Investment Management LLC now owns 74,373 shares of the company’s stock valued at $9,385,000 after buying an additional 15,402 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.